Established composition
Botanical identity and compounds measured in the bark or its preparations.
The Merchant · An evidence noteMonograph 03 / Composition
← Return to Ceylon CinnamonCeylon Cinnamon:
Species · composition · enquiry
Ceylon Cinnamon:
Composition and Health Evidence.
What is established, what has been observed in people, and what remains under enquiry.
In brief
Ceylon cinnamon’s low-coumarin profile distinguishes the species. Demonstrated clinical benefit from ordinary culinary use remains uncertain.
A necessary distinction
The species matters.
So does the kind of evidence.
Ceylon cinnamon is Cinnamomum verum. Its botanical identity and low-coumarin profile distinguish it from the cassia species commonly sold beneath the same general name. [01] [02]
Identity, however, is not itself proof of a health outcome. A compound measured in bark, an effect observed in a laboratory and a result recorded in a human trial answer different questions. This note keeps those questions separate.
How to read the record
Four kinds
of evidence.
Each kind answers a different question. None should be made to speak more confidently than its method permits.
Human research
Findings observed in people, read with the species, preparation and study design intact.
Experimental research
Cell and animal studies that suggest mechanisms, but do not establish a culinary benefit.
Historical context
Recorded use and cultural inheritance, kept distinct from evidence of clinical effect.
Established composition
Aromatic bark,
described precisely.
Ceylon cinnamon bark is characterised by a complex mixture of volatile and non-volatile constituents. Reviews identify cinnamaldehyde as a principal aromatic constituent of bark oil, accompanied by cinnamic acid, cinnamyl acetate, eugenol and numerous other compounds across different plant materials and preparations. [06]
The proportions are not fixed. Cultivar, growing conditions, the part of the tree, harvest, storage and method of extraction can all alter the chemical record. A statement about an essential oil or concentrated extract should therefore not be transferred uncritically to a culinary quill. [06]
Human research
Human findings,
with limits.
The United States National Center for Complementary and Integrative Health overview, last updated in November 2024, concluded that research did not clearly support cinnamon for any health condition. It also noted that species, plant part and preparation are often unclear, making studies difficult to compare. [01]
Two species-specific trials published subsequently add useful particulars, but not a settled conclusion. Their preparations, populations, durations and outcomes must remain attached to their results.
01Four months · extract
A defined extract in type 2 diabetes
A trial randomised 210 participants to 250 mg or 500 mg of a defined Cinnamomum zeylanicum extract, or placebo; 186 completed four-month follow-up. The authors reported improved fasting glucose and HbA1c measures in the extract groups and called the findings promising. They also called for further study. [03]
02Twelve weeks · extract
A mixed metabolic result
A second trial randomised 150 adults to 1,000 mg per day of a standardised extract or placebo; 127 were assessed at twelve weeks. Its primary LDL-cholesterol outcome was not significantly different, while a secondary fasting-glucose measure favoured the extract. Other listed lipid and HbA1c outcomes were not significantly different. [04]
Experimental research
Mechanisms under
examination.
Laboratory findings are valuable beginnings. They are not promises about what follows from eating cinnamon.
Antioxidant activity
Extracts and isolated constituents demonstrate antioxidant activity in laboratory systems. The significance for ordinary dietary use in people remains a separate question. [06] [07]
Activity in controlled settings
Cinnamon oils and compounds have been tested against microorganisms in vitro. Such concentrations and conditions do not directly describe an immune effect in a person. [06] [07]
Signals, not conclusions
Cinnamaldehyde and related compounds are studied for their interaction with inflammatory pathways. Much of this work remains cellular or preclinical. [06] [07]
Predominantly preclinical
A systematic review found forty studies concerning memory and learning: thirty-three animal studies, five laboratory studies and only two clinical studies. Human conclusions remain premature. [05]
Historical context
What history records—
and what it cannot prove.
Cinnamon has a long history in food, fragrance, ritual and medicinal preparations. These records concern different aromatic materials and traditions of use. Early references to “cinnamon” cannot always be assigned confidently to the species now called Cinnamomum verum, or traced to Sri Lankan origin. [08]
Historical accounts help us understand how cinnamon was valued and used. They do not, by themselves, establish the effectiveness or safety of a treatment. Those questions require evidence specific to the species, preparation, quantity and people studied. Here, the historical record provides cultural context; it remains distinct from the clinical research discussed above. [01] [08]
Read the history of Ceylon cinnamon →A note on proportion
Food, supplement
and treatment are not synonyms.
Authoritative guidance regards cinnamon as likely safe in the amounts ordinarily used as a food spice. Larger quantities, prolonged supplement use, pregnancy and possible interactions with medicines are different circumstances and merit professional guidance. [01]
The Merchant presents Ceylon cinnamon as a culinary ingredient. This page records evidence; it does not propose cinnamon as a treatment or a substitute for medical care.
Sources and method
For further
examination.
Editorial method
Prepared by The Merchant Editorial Desk as a selective, plain-language summary of the sources below. It is not a systematic review.
01
National Center for Complementary and Integrative HealthCinnamon: usefulness and safety
Public evidence overview; species, clinical evidence and safety↗02German Federal Institute for Risk AssessmentFrequently asked questions on coumarin in cinnamon
Official comparison of Ceylon and cassia coumarin profiles↗03Diabetes & Metabolic Syndrome · 2025Randomised trial of Cinnamomum zeylanicum extract
A four-month, extract-specific clinical trial in type 2 diabetes↗04PLOS ONE · 2025Ceylon cinnamon extract, lipid profile and glucose levels
A trial with a non-significant primary LDL-C outcome and a secondary fasting-glucose finding↗05Nutritional Neuroscience · 2024Cinnamon and cognitive function: a systematic review
Forty studies; the record was predominantly preclinical↗06Food Chemistry · 2021Phytochemical and pharmacological review of Cinnamomum verum
A review of taxonomy, composition and research gaps↗07BMC Complementary and Alternative Medicine · 2013Medicinal properties of true cinnamon: a systematic review
A species-specific review noting the scarcity of human evidence↗08CRC Press · 2004Cinnamon and Cassia: The Genus Cinnamomum
Introduction; historical names, trade and the limits of identifying early aromatics↗Return to the ingredient
Evidence in context.
Ceylon cinnamon in character.
Continue to the principal monograph for the species, Sri Lankan origin, quill craft, grade system and the House selections.
Explore Ceylon Cinnamon